AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback